Cargando...
Combination Medical Therapy for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
Medical therapy with α-adrenergic receptor blockers and 5-α-reductase inhibitors is currently considered first-line treatment for men with moderate to severe symptoms of benign prostatic hyperplasia (BPH). Given the success that has been realized with monotherapy with each of these agents, interest...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MedReviews, LLC
2005
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1477629/ https://ncbi.nlm.nih.gov/pubmed/16985890 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|